MedPath
HSA Approval

TIOSPIREX 13 mcg inhalation powder, hard capsule

SIN15858P

TIOSPIREX 13 mcg inhalation powder, hard capsule

TIOSPIREX 13 mcg inhalation powder, hard capsule

November 19, 2019

DKSH SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDKSH SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

RESPIRATORY (INHALATION)

Medical Information

R03BB04

tiotropium bromide

Manufacturer Information

DKSH SINGAPORE PTE. LTD.

Laboratorios Liconsa, S.A.

Active Ingredients

TIOTROPIUM BROMIDE 0.0156 mg EQV TIOTROPIUM

0.013mg

Tiotropium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TIOSPIREX 13 mcg inhalation powder, hard capsule - HSA Approval | MedPath